Suchergebnisse - "Dvorkin, Mikhail"

PubPharm (4)

1

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer : a randomized, controlled, double-blind phase 3 trial

enthalten in: Nature medicine | 2022

von Gogishvili, M. | Melkadze, T. | Makharadze, T. | +23

2

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

enthalten in: The New England journal of medicine | 2020

von Shaw, A. | Bauer, T. | de Marinis, F. | +112

CommentIn: Nat Rev Clin Oncol. 2021 Jan;18(1):6. - PMID 33262501

3

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

4

Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Pivot, X. | Bondarenko, I. | Nowecki, Z. | +14

1
[1]